Literature DB >> 30101550

The emergence of porcine circovirus 2 infections in the Northeastern part of India: A retrospective study from 2011 to 2017.

Nagendra Nath Barman1, Barnali Nath2, Vishnu Kumar2, Arnab Sen3, Tapan Kumar Dutta4, Biswajit Dutta1, Taibur Rahman1, Sachin Kumar2.   

Abstract

Porcine circovirus (PCV) infection has emerged as an alarming threat to the pig population of India, especially in the Northeastern region (NER) over the last 10 years. The present study is a comprehensive report of the seroepidemiology of PCV2 and its incidences in the pig population from organized and unorganized farms of the entire NER of India from 2011 to 2017. A total of 5697 serum samples were screened by ELISA and the mean positivity of PCV2 antibodies in suspected sera was 31.27%. A total of 22 confirmed cases of PCV2 infection were recorded during the years 2014-2017. Seroprevalence of PCV2 infection in sows causing reproductive disorders in NER suggested its higher incidence in organized farms (65.7%) as compared to unorganized farms (17.6%). A detailed pathological and histopathological examination of the tissue samples collected from the affected animals indicated the presence of PCV2. Molecular characterization and phylogenetic analysis of four PCV2 isolates depicted the circulation of PCV2d genotype in the states of Meghalaya and Assam.
© 2018 Blackwell Verlag GmbH.

Entities:  

Keywords:  Northeast India; circovirus; porcine; prevalence; serology

Mesh:

Substances:

Year:  2018        PMID: 30101550     DOI: 10.1111/tbed.12977

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  1 in total

1.  Isolation and genetic analysis of Porcine circovirus 2 in southern India evidences high circulation of Porcine circovirus 2d genotype.

Authors:  S Parthiban; A Ramesh; Anbu Kumar Karuppannan; G Dhinakar Raj; S Hemalatha; M Parthiban; K Senthilkumar; D Balasubramaniyam; R Sumanth Kumar; S Ranganatha; Chintu Ravishankar
Journal:  Mol Biol Rep       Date:  2022-10-10       Impact factor: 2.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.